Insider Trading February 20, 2026 10:32 PM

Ensign Group Legal Chief Disposes $105,115 in Stock After Option Exercise

VP and Chief Legal Officer executes option exercise and sale under pre-arranged 10b5-1 plan as stock trades near 52-week high

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
ENSG

Beverly B. Wittekind, Vice President and Chief Legal Officer of The Ensign Group (ENSG), sold 500 shares of company stock on February 19, 2026, for $210.23 per share, netting $105,115. The transaction followed an option exercise for 500 shares at $83.64 per share, and was carried out under a Rule 10b5-1 trading plan established in September 2025. The activity occurred while the stock traded near its 52-week high and after the company reported stronger-than-expected fourth-quarter adjusted EPS.

Ensign Group Legal Chief Disposes $105,115 in Stock After Option Exercise
ENSG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Beverly B. Wittekind sold 500 shares of Ensign Group common stock on February 19, 2026, for $210.23 per share, totaling $105,115.
  • Wittekind exercised options to acquire 500 shares at $83.64 per share (aggregate $41,820) and sold those shares; 113 shares were withheld for taxes valued at $204.78 per share (totaling $23,140).
  • The sale was made under a Rule 10b5-1 trading plan adopted on September 2, 2025, and occurred while ENSG traded near its 52-week high following a 67% year-over-year gain.

Beverly B. Wittekind, who serves as Vice President and Chief Legal Officer at The Ensign Group (NASDAQ: ENSG), reported a sale of 500 common shares on February 19, 2026, at a per-share price of $210.23, yielding $105,115 in gross proceeds.

According to a Form 4 filed with the U.S. Securities and Exchange Commission, Wittekind concurrently exercised stock options to acquire 500 shares at an exercise price of $83.64, for a stated aggregate exercise cost of $41,820. The filing notes that the 500 shares obtained through the option exercise were subsequently sold.

The issuer withheld 113 shares to satisfy income tax obligations related to the transaction. Those withheld shares were valued in the filing at $204.78 per share, producing a reported total of $23,140 attributed to the withholding.

The insider sale and option exercise were executed under a pre-arranged Rule 10b5-1 trading plan that Wittekind adopted on September 2, 2025. The share sale took place as The Ensign Group stock traded close to its 52-week high of $216.92, after the share price rose approximately 67% over the prior 12 months.

Separately noted in the filing and related coverage, InvestingPro analysis indicates the company appears overvalued at current levels when assessed against Fair Value metrics. The coverage references a comprehensive Pro Research Report for ENSG available on the InvestingPro platform for investors seeking further valuation detail.

Recent company results provide context to investor sentiment. The Ensign Group reported fiscal fourth-quarter 2025 adjusted earnings per share of $1.82, ahead of the $1.75 estimate, while revenue came in at $1.36 billion versus an anticipated $1.37 billion. The results and margin performance contributed to analyst activity; Truist Securities raised its price target on the stock from $200 to $215 while maintaining a Hold rating, citing the company’s stronger-than-expected margins and bottom-line results.

All filings and figures referenced in this report are those disclosed in the Form 4 filing and the company’s reported quarterly results.

Risks

  • Valuation risk: InvestingPro analysis cited in the filing indicates the company appears overvalued based on Fair Value metrics, which may affect investor expectations.
  • Revenue uncertainty: The company reported a slight revenue miss in Q4 2025, posting $1.36 billion versus the $1.37 billion anticipated, highlighting potential top-line sensitivity.
  • Insider liquidity events: The exercise and sale of options by a senior executive, even under a pre-arranged trading plan, can inject additional supply into the market, which may influence short-term share dynamics.

More from Insider Trading

Cavco Industries CFO Aden Allison Executes Pre-arranged Sale of 1,473 Shares Jun 26, 2026 Spyre Therapeutics CFO Burrows Executes $1.3M Stock Sale Amid Clinical Momentum Jun 26, 2026 Natera Legal Officer Daniel Rabinowitz Executes $8.45 Million Share Sale Under Pre-Arranged Plan Jun 26, 2026 Natera Director Herm Rosenman Offloads $4.13M in NTRA Shares Jun 26, 2026 NextNav COO Susan Insley Executes Stock Sale Under Pre-Existing Trading Plan Jun 26, 2026